Skip to content

Savitz Ryan

Reporting owner on Forms 3, 4 and 5, CIK 1992324.

Savitz Ryan reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.

Issuers

IssuerRoles in the latest filingFilingsLast filed
DNTH · Dianthus Therapeutics, Inc. /DE/CIK 1690585officer (EVP, CFO & CBO)12026-11-12

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-12M exercised+1,339$21.771,339Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-12M exercised+16,385$22.0717,724Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-12S sold-17,724$90.560Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-12M exercised-1,339$043,759Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-12M exercised-16,385$090,625Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-11M exercised+1,744$21.771,744Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-11M exercised+1,300$22.073,044Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-11S sold-3,044$90.030Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-11M exercised-1,744$045,098Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-11M exercised-1,300$0107,010Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-10M exercised+1,301$21.771,301Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-10M exercised+1,260$22.072,561Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-10S sold-2,561$90.140Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-10M exercised-1,301$046,842Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-10M exercised-1,260$0108,310Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09M exercised+29,276$17.8829,276Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09M exercised+20,608$21.7749,884Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09M exercised+40,430$22.0790,314Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09M exercised+10,399$8.44100,713Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-300$85.16100,413Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-700$86.799,713Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-1,736$88.8497,977Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-37,517$90.1260,460Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-58,396$90.92,064Form 4
DNTH · Dianthus Therapeutics, Inc.…Common Stock2026-11-09S sold-2,064$91.590Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-09M exercised-29,276$042,500Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-09M exercised-20,608$048,143Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-09M exercised-40,430$0109,570Form 4
DNTH · Dianthus Therapeutics, Inc.…Stock Option (Right to Buy), derivative2026-11-09M exercised-10,399$00Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001992324-26-000010 Dianthus Therapeutics, Inc. /DE/2026-11-12